Craig A Collard
CIK 1363558 · Chief Executive Officer · last filed 2026-05-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$303.2K
Companies
5
Total Filings
58
Lifetime Open-Market Net
-$17.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRTX | Chief Executive Officer | 757,885 | $0.40 | $303.2K | $138.0K | 24 | 2026-05-04 |
| OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Director | 0 | $20.65 | $0 | $689.0K | 11 | 2023-03-03 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $310.9K | 4 | 2022-07-01 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Chief Executive Officer | 0 | $1.95 | $0 | -$18.22M | 9 | 2014-02-04 |
| CORNERSTONE THERAPEUTICS INC (CRTXD) Delisted | President and CEO | 3,202,225 | — | — | $0 | 1 | 2008-11-04 |
Recent Filings · Page 4 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-27 | — | Buy (P) | +60,000 | $0 | |
| 2022-09-26 | — | Buy (P) | +120,000 | $0 | |
| 2022-07-01 | Sierra Oncology, Inc. (SRRA) Delisted | Disp (D) | −13,500 | -$742.5K | EDGAR |
| 2022-06-29 | — | Grant (A) | +114,414 | $0 | |
| 2022-06-14 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2022-06-13 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +5,700 | $63.3K | EDGAR |
| 2022-05-17 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +27,150 | $367.6K | EDGAR |
| 2022-05-16 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +3,689 | $38.7K | EDGAR |
| 2022-01-10 | — | Exer (X) | +52,939 | $134.5K | |
| 2021-11-24 | Sierra Oncology, Inc. (SRRA) Delisted | Buy (P) | +13,500 | $310.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.